Investment in antiviral drugs: a real options approach

B-Tier
Journal: Health Economics
Year: 2010
Volume: 19
Issue: 10
Pages: 1240-1254

Authors (3)

Arthur E. Attema (Erasmus Universiteit Rotterdam) Anna K. Lugnér (not in RePEc) Talitha L. Feenstra (not in RePEc)

Score contribution per author:

0.670 = (α=2.01 / 3 authors) × 1.0x B-tier

α: calibrated so average coauthorship-adjusted count equals average raw count

Abstract

Real options analysis is a promising approach to model investment under uncertainty. We employ this approach to value stockpiling of antiviral drugs as a precautionary measure against a possible influenza pandemic. Modifications of the real options approach to include risk attitude and deviations from expected utility are presented. We show that risk aversion counteracts the tendency to delay investment for this case of precautionary investment, which is in contrast to earlier applications of risk aversion to real options analysis. Moreover, we provide a numerical example using real world data and discuss the implications of real options analysis for health policy. Suggestions for further extensions of the model and a comparison with the expected value of information analysis are put forward. Copyright © 2009 John Wiley & Sons, Ltd.

Technical Details

RePEc Handle
repec:wly:hlthec:v:19:y:2010:i:10:p:1240-1254
Journal Field
Health
Author Count
3
Added to Database
2026-01-24